Evidence map›Paper›PMID 33627215›Full record

ArticleZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics2021

[Application of double plasma molecular adsorption system in children with acute liver failure].

Jie He, Xin-Ping Zhang, Xiong Zhou, Zi-Li Cai, Xia-Yan Kang, Wei Duan, Wen-Jiao Zhao, Zheng-Hui Xiao

Abstract read
In one paragraph

Article in Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Non-bioartificial liver support system in the treatment of pediatric acute liver failure.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Review
  4. Article
  5. [Therapeutic plasma exchange in the pediatric intensive care unit: a single-center retrospective study].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2022
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jie HeIntensive Care Unit, Hunan Children's Hospital, Changsha 410007, China.
Xin-Ping ZhangIntensive Care Unit, Hunan Children's Hospital, Changsha 410007, China.
Xiong ZhouIntensive Care Unit, Hunan Children's Hospital, Changsha 410007, China.
Zi-Li CaiIntensive Care Unit, Hunan Children's Hospital, Changsha 410007, China.
Xia-Yan KangIntensive Care Unit, Hunan Children's Hospital, Changsha 410007, China.
Wei DuanIntensive Care Unit, Hunan Children's Hospital, Changsha 410007, China.
Wen-Jiao ZhaoIntensive Care Unit, Hunan Children's Hospital, Changsha 410007, China.
Zheng-Hui XiaoIntensive Care Unit, Hunan Children's Hospital, Changsha 410007, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo study the efficacy and safety of double plasma molecular absorption system (DPMAS) in the treatment of pediatric acute liver failure (PALF).

methodsA prospective analysis was performed on the medical data of children with PALF who were hospitalized in the Intensive Care Unit (ICU), Hunan Children's Hospital, from March 2018 to June 2020. The children were randomly divided into two groups:plasma exchange group (PE group) and DPMAS group (

resultsCompared with the PE group, the DPMAS group had a significantly lower number of times of artificial liver support therapy and a significantly shorter duration of ICU stay (

conclusionsDPMAS is safe and effective in the treatment of PALF and can thus be used as an alternative to artificial liver support therapy.

Indexed as

Liver Failure, AcuteAdsorptionChildHumansPlasmaPlasma ExchangeProspective Studies

Identifiers

PMID33627215
PMCPMC7921536

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.